Evolution of plasminogen activator inhibitor type 1 in patients with septic shock — correlation with cytokine concentrations

This publication has 20 references indexed in Scilit:

• Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways
  Blood, 1990
• Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products
  Blood, 1990
• Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal Subjects
  New England Journal of Medicine, 1990
• Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock
  The Journal of Infectious Diseases, 1990
• Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease
  Thrombosis Research, 1990
• Coagulation, fibrinolysis, and kallikrein systems in sepsis
  Critical Care Medicine, 1989
• Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal Subjects
  New England Journal of Medicine, 1989
• The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
  The Journal of Experimental Medicine, 1989
• Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious Purpura
  New England Journal of Medicine, 1988
• Multiple-Organ-Failure Syndrome
  Archives of Surgery, 1986